EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy

Alexandros Pailas, Ana Catarina Vales de Almeida, Miriam Torres-Fernández, Anthony Chalmers, Michel Mittelbronn, Eric Van Dyck iD

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology Advances, online erschienen am 09.07.2026. Verfasst von Alexandros Pailas und 5 weiteren Autor:innen. Beteiligte Einrichtung: DNA Repair and Chemoresistance Group, Department of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg. Die Arbeit nennt 362 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund for Scientific Research (F.R.S-FNRS)-Télévie grants, the Luxembourg National Research Fund, The Action Lions “Vaincre le Cancer”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Replication stress (RS) encompasses states of impaired DNA replication progression associated with fork slowing, stalling, or collapse. RS triggers a specialized branch of the DNA damage response (DDR) called the RS response (RSR) and constitutes a major source of genomic instability, which is a key hallmark of cancer. Cancer cells face high basal levels of RS due to sustained proliferative signaling. Besides endogenous stimuli, RS can be induced by exogenous sources such as chemotherapeutic drugs. In glioblastoma (GBM), the most aggressive primary brain tumor, chronic RS leading to DDR activation is thought to drive enhanced DNA repair and treatment resistance. While chromosomal instability associated with DDR defects drives tumorigenesis, the need to preserve genomic stability to maintain fitness fosters addiction to redundant pathways promoting fork integrity. Targeting these pathways is a promising anti-cancer strategy currently undergoing clinical evaluation. In this review, we provide a molecular overview of RS and the RSR. We also explore the sources of RS in gliomas, along with the biological processes and tumor-specific features that influence the RSR in GBM cells. We then delve into the strategies developed to exploit RS, including strategies harnessing the DDR to foster antitumor immunity.

Schlagwörter

Stichwörter der Autor:innen

DNA damage response (DDR)chemotherapyglioblastoma (GBM)immunotherapyreplication stress response (RSR)

Autor:innen und Institutionen

  • DNA Repair and Chemoresistance Group, Department of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
  • Faculty of Science, Technology and Communication, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Department of Health, Medicine and Life Sciences (DHML), Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Division of Neuropathology, Department of Pathology and Neuropathology, Medical Faculty, University of Cologne, Cologne, Germany.

ORCID-Profile: Eric Van Dyck

Förderung

  • Fund for Scientific Research (F.R.S-FNRS)-Télévie grants
  • the Luxembourg National Research Fund
  • The Action Lions “Vaincre le Cancer”
  • Fondation du Pélican de Mie et Pierre Hippert-Faber, under the aegis of the Fondation de Luxembourg

Zitieren

APA

Pailas, A., Vales de Almeida, A. C., Torres-Fernández, M., Chalmers, A., Mittelbronn, M., & Van Dyck, E. (2026). Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag177

Vancouver

Pailas A, Vales de Almeida AC, Torres-Fernández M, Chalmers A, Mittelbronn M, Van Dyck E. Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag177

BibTeX
@article{Pailas2026,
  author = {Pailas, Alexandros and Vales de Almeida, Ana Catarina and Torres-Fernández, Miriam and Chalmers, Anthony and Mittelbronn, Michel and Van Dyck, Eric},
  title = {Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag177}
}
Kostenlos starten →